Tissue Diagnostics Market Report Scope & Overview:

The Tissue Diagnostics Market Size was valued at USD 5.28 billion in 2022, and is expected to reach USD 8.61 billion by 2030 and grow at a CAGR of 6.3% over the forecast period 2023-2030.

The procedure of identifying a specific tissue that was acquired is known as tissue diagnostics. It can also be described as making a diagnosis of a specific tissue, which includes taking measurements, describing it, and looking for any anomalies that may be present. This procedure aids in determining the patient's health and disease state. The three main types of tissue diagnostics are in-situ hybridization, hematoxylin and eosin (H&E), and immunohistochemistry (IHC), with the latter being the most widely used technique.

Tissue Diagnostics Market Revenue Analysis

Get more information on Tissue Diagnostics Market - Request Sample Report

Personalized diagnosis and therapy are frequently made possible by tissues, and samples are typically made up of tissue fragments obtained by a variety of techniques, such as small biopsies and big specimens taken during surgery. The market for tissue diagnostics is expected to expand in the approaching years due to important reasons such rising healthcare costs and technical breakthroughs in this area. The International Agency for Research on Cancer (IARC) estimates that, in addition to other factors including poor food, inactivity, and smoking, the worldwide burden of cancer will rise to 21 million new cases and more than 12 million deaths from the disease.



  • Increasing costs for healthcare

  • Increasing cancer incidence

  • Constructing a system for cancer diagnostics

  • Digital pathology is in greater demand

  • Expanding the number of available reimbursements

  • Expanding private diagnostic facilities worldwide

  • Increasing numbers of elderly people, which is followed by an increase in chronic and infectious disorders


  • Extremely strong consolidation

  • Reimbursement problems and high diagnostic costs


  • BRICS nations provide numerous opportunities

  • Increasing demand for customized medications

  • There are more and more drug-related clinical trials

  • Emerging markets will present substantial business prospects


  • Professionals lacking in expertise

  • Refurbished goods are accessible

  • Recalls and defective products

  • Regulations that are very strict

  • Middle- and low-income nations suffer from a lack of infrastructure and a lack of awareness.


The COVID-19 epidemic has had an effect on the global pharmaceutical, diagnostics, and healthcare industries, as well as the tissue diagnostics sector.

The market was favorably impacted by COVID-19 as a result of the rise in popularity of high-throughput, sequencing-based diagnostic testing.

By Product

Instruments and Reagents & Consumables are the market segments. The consumables segment is anticipated to experience the largest growth rate over the next few years, mostly due to its affordability, strong demand, and simplicity of use. In addition, one of the key elements most likely to fuel the market's expansion internationally is the rising number of reagent rental agreements.

By Technology

The market is divided into the following categories: Digital Pathology and Workflow Management, Immunohistochemistry (IHC), In Situ Hybridization (ISH), and Special Staining. The segment for immunohistochemistry, which is generally utilised in tissue diagnostics, is anticipated to develop at the highest rate in the next years. This is mostly due to the rising global prevalence of chronic diseases.

By End User

Hospitals, pharmaceutical companies, research laboratories, and contract research organizations make up the market segments. One of the key drivers accelerating market expansion and demand during the projection period is the rapidly expanding infrastructure for cancer diagnosis.


By Product

  • Consumables

  • Instruments

By Disease

  • Breast Cancer

  • Gastric Cancer

  • Lymphoma

  • Prostate Cancer

  • Non-Small Cell Lung Cancer

By Technology

  • Immunohistochemistry (IHC)

  • In-Situ Hybridization (ISH)

  • Digital Pathology & Workflow Management

  • Special Staining

By End User

  • Hospitals, Research Laboratories

  • Pharmaceutical Companies

  • Contract Research Organizations

Tissue Diagnostics Market Segmentation Analysis

Need any customization research on Tissue Diagnostics Market - Enquiry Now


North America, Asia Pacific, Europe, and the rest of the world make up the market segments. It's expected that North America will control the market. The market in North America is expanding mainly because to the simple accessibility of cutting-edge technology, the rising prevalence of hereditary and lifestyle-related chronic diseases, and the country's increasingly ageing population.


  • North America

    • USA

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • The Netherlands

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • south Korea

    • China

    • India

    • Australia

    • Rest of Asia-Pacific

  • The Middle East & Africa

    • Israel

    • UAE

    • South Africa

    • Rest of Middle East & Africa

  • Latin America

    • Brazil

    • Argentina

    • Rest of Latin America


Some of the major key players are Agilent Technologies, Inc., Bio Sb, Cell Signaling Technology, Inc., Danaher Corporation, Sigma-Aldrich Corporation, Abbott Laboratories, Inc., Sakura Finetek Japan Co., Ltd., Bio genex Laboratories, Thermo Fisher Scientific, F. Hoffman-La Roche AG. and other players.

Abbott Laboratories Inc-Company Financial Analysis

Company Landscape Analysis

Tissue Diagnostics Market Report Scope:

Report Attributes Details
Market Size in 2022 US$ 5.28 Billion
Market Size by 2030 US$ 8.61 Billion
CAGR CAGR of 6.3% From 2023 to 2030
Base Year 2022
Forecast Period 2023-2030
Historical Data 2020-2021
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Product (Consumables, Instruments)
• By Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer)
• By Technology (Immunohistochemistry (IHC), In-Situ Hybridization (ISH), Digital Pathology & Workflow Management, Special Staining)
• By End User (Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Agilent Technologies, Inc., Bio Sb, Cell Signaling Technology, Inc., Danaher Corporation, Sigma-Aldrich Corporation, Abbott Laboratories, Inc., Sakura Finetek Japan Co., Ltd., Bio genex Laboratories, Thermo Fisher Scientific, F. Hoffman-La Roche AG
Key Drivers • Increasing costs for healthcare
• Increasing cancer incidence
RESTRAINTS • Extremely strong consolidation
• Reimbursement problems and high diagnostic costs

Frequently Asked Questions

Ans. The Tissue Diagnostics Market is to grow at a CAGR of 6.3% during the forecast period 2023-2030.

Ans BRICS nations provide numerous opportunities, increasing demand for customized medications, and There are more and more drug-related clinical trials are the opportunities of the market.

Ans. The Tissue Diagnostics Market is valued at US$ 5.28 Bn in 2022.

Ans. It's expected that North America will control the market.

Ans.  Consumables, and Instruments are sub segments of by product of the Tissue Diagnostics Market.

Table of Contents

 1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

4. Impact Analysis

4.1 COVID-19 Impact Analysis

4.2 Impact of Ukraine- Russia War

4.3 Impact of Ongoing Recession

4.3.1 Introduction

4.3.2 Impact on major economies US Canada Germany France United Kingdom China Japan South Korea Rest of the World

5. Value Chain Analysis

6. Porter’s 5 forces model

7.  PEST Analysis


8. Tissue Diagnostics Market Segmentation, By Product

8.1 Consumables

8.2 Instruments

9. Tissue Diagnostics Market Segmentation, By Disease

9.1 Breast Cancer

9.2 Gastric Cancer

9.3 Lymphoma

9.4 Prostate Cancer

9.5 Non-Small Cell Lung Cancer

10. Tissue Diagnostics Market Segmentation, By Technology

10.1 Immunohistochemistry (IHC)

10.2 In-Situ Hybridization (ISH)

10.3 Digital Pathology & Workflow Management

10.4 Special Staining

11. Tissue Diagnostics Market Segmentation, By End User

11.1 Hospitals, Research Laboratories

11.2 Pharmaceutical Companies

11.3 Contract Research Organizations

12. Regional Analysis

12.1 Introduction

12.2 North America

12.2.1 USA

12.2.2 Canada

12.2.3 Mexico

12.3 Europe

12.3.1 Germany

12.3.2 UK

12.3.3 France

12.3.4 Italy

12.3.5 Spain

12.3.6 The Netherlands

12.3.7 Rest of Europe

12.4 Asia-Pacific

12.4.1 Japan

12.4.2 South Korea

12.4.3 China

12.4.4 India

12.4.5 Australia

12.4.6 Rest of Asia-Pacific

12.5 The Middle East & Africa

12.5.1 Israel

12.5.2 UAE

12.5.3 South Africa

12.5.4 Rest

12.6 Latin America

12.6.1 Brazil

12.6.2 Argentina

12.6.3 Rest of Latin America

13. Company Profiles

13.1 Agilent Technologies, Inc.

13.1.1 Financial

13.1.2 Products/ Services Offered

13.1.3 SWOT Analysis

13.1.4 The SNS view

13.2 Bio Sb

13.3 Cell Signaling Technology, Inc.

13.4 Danaher Corporation

13.5 Sigma-Aldrich Corporation

13.6 Abbott Laboratories, Inc.

13.7 Sakura Finetek Japan Co., Ltd.

13.8 Bio genex Laboratories

13.9 Thermo Fisher Scientific

13.10 F. Hoffman-La Roche AG

14. Competitive Landscape

14.1 Competitive Benchmark

14.2 Market Share Analysis

14.3 Recent Developments

15. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.


The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

Start a Conversation

Hi! Click one of our member below to chat on Phone